A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.
Clinical trial NCT00144105 · TERMINATED
Trial details
- NCT number
- NCT00144105
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2006-11-01
- Enrollment
- 562
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.